These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 15054831

  • 1. Systemic anaphylactic reaction following intrathecal administration of methotrexate in adult patient with primary central nervous system lymphoma.
    Elkiran ET, Altundag K, Aksoy S, Onal IK, Tekuzman G.
    Am J Hematol; 2004 Apr; 75(4):265. PubMed ID: 15054831
    [No Abstract] [Full Text] [Related]

  • 2. Anaphylactoid reaction to high-dose methotrexate and re-administration after a successful desensitization.
    Caldeira T, Costa V, Silva I, Oliva T, Norton L.
    Pediatr Hematol Oncol; 2008 Mar; 25(2):131-4. PubMed ID: 18363180
    [Abstract] [Full Text] [Related]

  • 3. Intrathecal methotrexate-induced acute cerebellar syndrome.
    Ferhanoglu B, Ongören S, Ar CM, Uzel B, Forta H, Necioglu D.
    Ann Hematol; 2003 Apr; 82(4):241-3. PubMed ID: 12707728
    [Abstract] [Full Text] [Related]

  • 4. Is intrathecal methotrexate necessary in the treatment of primary CNS lymphoma?
    Khan RB, Shi W, Thaler HT, DeAngelis LM, Abrey LE.
    J Neurooncol; 2002 Jun; 58(2):175-8. PubMed ID: 12164690
    [Abstract] [Full Text] [Related]

  • 5. Intracerebral hematoma as a complication of intrathecal methotrexate administration.
    Boran P, Tokuc G, Boran BO, Oktem S.
    Pediatr Blood Cancer; 2008 Jan; 50(1):152-4. PubMed ID: 16615061
    [Abstract] [Full Text] [Related]

  • 6. [Primary central nervous system lymphoma: diagnosis, management and current topics].
    Arita N.
    No To Shinkei; 2004 Mar; 56(3):195-203. PubMed ID: 15112444
    [No Abstract] [Full Text] [Related]

  • 7. Intrathecal methotrexate-induced acute chorea.
    Necioğlu Orken D, Yldrmak Y, Kenangil G, Kandraloğlu N, Forta H, Celik M.
    J Pediatr Hematol Oncol; 2009 Jan; 31(1):57-8. PubMed ID: 19125090
    [Abstract] [Full Text] [Related]

  • 8. Ogilvie's syndrome during chemotherapy with high-dose methotrexate for primary CNS lymphoma.
    Xie H, Peereboom DM.
    J Clin Oncol; 2012 Jul 20; 30(21):e192-4. PubMed ID: 22711852
    [No Abstract] [Full Text] [Related]

  • 9. Systemic near-fatal anaphylactic reaction after intrathecal methotrexate administration.
    Devecioğlu O, Biner B, Karaböcüoğlu M, Unüvar A, Ağaoğlu L.
    Med Pediatr Oncol; 2000 Feb 20; 34(2):151-2. PubMed ID: 10657881
    [No Abstract] [Full Text] [Related]

  • 10. Leukocytoclastic Vasculitis and Desensitization to High-dose Methotrexate in Primary Central Nervous System Lymphoma.
    Hanna C, Villa D, Irani C, Ghosn M, El Rassy E.
    Clin Lymphoma Myeloma Leuk; 2018 May 20; 18(5):e197-e200. PubMed ID: 29605422
    [No Abstract] [Full Text] [Related]

  • 11. Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent patients.
    Cohen IJ.
    Pediatr Blood Cancer; 2011 Jul 01; 56(7):1151. PubMed ID: 21312324
    [No Abstract] [Full Text] [Related]

  • 12. Renal dysfunction during and after high-dose methotrexate.
    Green MR, Chamberlain MC.
    Cancer Chemother Pharmacol; 2009 Mar 01; 63(4):599-604. PubMed ID: 18504579
    [Abstract] [Full Text] [Related]

  • 13. Treatment of accidental intrathecal methotrexate overdose with intrathecal carboxypeptidase G2.
    Widemann BC, Balis FM, Shalabi A, Boron M, O'Brien M, Cole DE, Jayaprakash N, Ivy P, Castle V, Muraszko K, Moertel CL, Trueworthy R, Hermann RC, Moussa A, Hinton S, Reaman G, Poplack D, Adamson PC.
    J Natl Cancer Inst; 2004 Oct 20; 96(20):1557-9. PubMed ID: 15494606
    [Abstract] [Full Text] [Related]

  • 14. Re: Maculopathy as a complication of blood-brain barrier disruption in patients with central nervous system lymphoma.
    Goldstein DA, Tessler HH.
    Am J Ophthalmol; 2007 Dec 20; 144(6):976; author reply 976. PubMed ID: 18036877
    [No Abstract] [Full Text] [Related]

  • 15. Myelopathy due to intrathecal chemotherapy: magnetic resonance imaging findings.
    Counsel P, Khangure M.
    Clin Radiol; 2007 Feb 20; 62(2):172-6. PubMed ID: 17207701
    [No Abstract] [Full Text] [Related]

  • 16. Subacute leukencephalopathy after low-dose intrathecal methotrexate in an adolescent heterozygous for the MTHFR C677T polymorphism.
    Strunk T, Gottschalk S, Goepel W, Bucsky P, Schultz C.
    Med Pediatr Oncol; 2003 Jan 20; 40(1):48-50. PubMed ID: 12426687
    [No Abstract] [Full Text] [Related]

  • 17. Transient encephalopathy following high-dose methotrexate.
    Lee AC, Li CH, Wong YC.
    Med Pediatr Oncol; 2003 Jul 20; 41(1):101. PubMed ID: 12764767
    [No Abstract] [Full Text] [Related]

  • 18. Delayed renal excretion of methotrexate after a severe anaphylactic reaction to methotrexate in a child with osteosarcoma.
    Ozguven AA, Uysal K, Gunes D, Koroglu T, Gurcu O, Olgun N.
    J Pediatr Hematol Oncol; 2009 Apr 20; 31(4):289-91. PubMed ID: 19346884
    [Abstract] [Full Text] [Related]

  • 19. [Acute respiratory distress syndrome due to pneumonitis following intrathecal methotrexate administration].
    Le Guillou F, Dominique S, Dubruille V, Contentin N, Tilly H, Nouvet G.
    Rev Mal Respir; 2003 Apr 20; 20(2 Pt 1):273-7. PubMed ID: 12844025
    [Abstract] [Full Text] [Related]

  • 20. Clinical utility and pharmacology of high-dose methotrexate in the treatment of primary CNS lymphoma.
    Green MR, Chowdhary S, Lombardi KM, Chalmers LM, Chamberlain M.
    Expert Rev Neurother; 2006 May 20; 6(5):635-52. PubMed ID: 16734512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.